BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 37857362)

  • 1. Metabolic Perturbations Associated with an Exposure Mixture of Per- and Polyfluoroalkyl Substances in the Atlanta African American Maternal-Child Cohort.
    Liang D; Taibl KR; Dunlop AL; Barr DB; Ryan PB; Everson T; Huels A; Tan Y; Panuwet P; Kannan K; Marsit C; Jones DP; Eick SM
    Environ Sci Technol; 2023 Oct; 57(43):16206-16218. PubMed ID: 37857362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Per- and polyfluoroalkyl substance (PFAS) exposure, maternal metabolomic perturbation, and fetal growth in African American women: A meet-in-the-middle approach.
    Chang CJ; Barr DB; Ryan PB; Panuwet P; Smarr MM; Liu K; Kannan K; Yakimavets V; Tan Y; Ly V; Marsit CJ; Jones DP; Corwin EJ; Dunlop AL; Liang D
    Environ Int; 2022 Jan; 158():106964. PubMed ID: 34735953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with hypertensive disorders of pregnancy in the Atlanta African American Maternal-Child cohort.
    Thompson M; Eatman JA; Dunlop AL; Barr DB; Kannan K; Corwin EJ; Ryan PB; Panuwet P; Yakimavets V; Taibl KR; Tan Y; Liang D; Eick SM
    Chemosphere; 2024 Jun; 357():142052. PubMed ID: 38631500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of a Prenatal Serum Per- and Polyfluoroalkyl Substance Mixture with the Cord Serum Metabolome in the HOME Study.
    Hall AM; Fleury E; Papandonatos GD; Buckley JP; Cecil KM; Chen A; Lanphear BP; Yolton K; Walker DI; Pennell KD; Braun JM; Manz KE
    Environ Sci Technol; 2023 Dec; 57(51):21627-21636. PubMed ID: 38091497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Per- and polyfluoroalkyl substances and psychosocial stressors have a joint effect on adverse pregnancy outcomes in the Atlanta African American Maternal-Child cohort.
    Eick SM; Barr DB; Brennan PA; Taibl KR; Tan Y; Robinson M; Kannan K; Panuwet P; Yakimavets V; Ryan PB; Liang D; Dunlop AL
    Sci Total Environ; 2023 Jan; 857(Pt 2):159450. PubMed ID: 36252672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum per- and polyfluoroalkyl substance (PFAS) concentrations and predictors of exposure among pregnant African American women in the Atlanta area, Georgia.
    Chang CJ; Ryan PB; Smarr MM; Kannan K; Panuwet P; Dunlop AL; Corwin EJ; Barr DB
    Environ Res; 2021 Jul; 198():110445. PubMed ID: 33186575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with attention-deficit/hyperactivity disorder and autism spectrum disorder in children.
    Skogheim TS; Weyde KVF; Aase H; Engel SM; Surén P; Øie MG; Biele G; Reichborn-Kjennerud T; Brantsæter AL; Haug LS; Sabaredzovic A; Auyeung B; Villanger GD
    Environ Res; 2021 Nov; 202():111692. PubMed ID: 34293314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of single and multiple per- and polyfluoroalkyl substance (PFAS) exposure with vitamin D biomarkers in African American women during pregnancy.
    Chang CJ; Barr DB; Zhang Q; Dunlop AL; Smarr MM; Kannan K; Panuwet P; Tangpricha V; Shi L; Liang D; Corwin EJ; Ryan PB
    Environ Res; 2021 Nov; 202():111713. PubMed ID: 34284018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal exposure to per- and polyfluoroalkyl substances and maternal and neonatal thyroid function in the Project Viva Cohort: A mixtures approach.
    Preston EV; Webster TF; Claus Henn B; McClean MD; Gennings C; Oken E; Rifas-Shiman SL; Pearce EN; Calafat AM; Fleisch AF; Sagiv SK
    Environ Int; 2020 Jun; 139():105728. PubMed ID: 32311629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemic-specific association of maternal exposure to per- and polyfluoroalkyl substances (PFAS) and their components with maternal glucose metabolism: A cross-sectional analysis in a birth cohort from Hong Kong.
    Yang A; Tam CHT; Wong KK; Ozaki R; Lowe WL; Metzger BE; Chow E; Tam WH; Wong CKC; Ma RCW
    Sci Total Environ; 2024 Mar; 917():170220. PubMed ID: 38278268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of maternal high fat diet on mouse pup metabolic endpoints following perinatal PFAS and PFAS mixture exposure.
    Marques ES; Agudelo J; Kaye EM; Modaresi SMS; Pfohl M; Bečanová J; Wei W; Polunas M; Goedken M; Slitt AL
    Toxicology; 2021 Oct; 462():152921. PubMed ID: 34464680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between a Mixture of Per- and Polyfluoroalkyl Substances (PFAS) and Inflammatory Biomarkers in the Atlanta African American Maternal-Child Cohort.
    Tan Y; Taibl KR; Dunlop AL; Barr DB; Panuwet P; Yakimavets V; Kannan K; Corwin EJ; Ryan PB; Eatman JA; Liang D; Eick SM
    Environ Sci Technol; 2023 Sep; 57(36):13419-13428. PubMed ID: 37649345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of per- and polyfluoroalkyl substances with maternal early second trimester sex-steroid hormones.
    Pacyga DC; Papandonatos GD; Rosas L; Whalen J; Smith S; Park JS; Gardiner JC; Braun JM; Schantz SL; Strakovsky RS
    Int J Hyg Environ Health; 2024 Jun; 259():114380. PubMed ID: 38657330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of prenatal exposure to perfluoroalkyl substances with preterm birth: A family-based birth cohort study.
    Yu Y; Qin XD; Bloom MS; Chu C; Dai X; Li QQ; Chen ZX; Kong ML; Xie YQ; Meng WJ; Yang BY; Hu LW; Zeng XW; Zhao XM; Zhou Y; Dong GH
    Environ Res; 2022 Nov; 214(Pt 1):113803. PubMed ID: 35810818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exposure to perfluoroalkyl substances and neurodevelopment in 2-year-old children: A prospective cohort study.
    Luo F; Chen Q; Yu G; Huo X; Wang H; Nian M; Tian Y; Xu J; Zhang J; Zhang J;
    Environ Int; 2022 Aug; 166():107384. PubMed ID: 35834943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of per- and polyfluoroalkyl substances with maternal metabolic and inflammatory biomarkers in early-to-mid-pregnancy.
    Cinzori ME; Pacyga DC; Rosas L; Whalen J; Smith S; Park JS; Geiger SD; Gardiner JC; Braun JM; Schantz SL; Strakovsky RS
    Environ Res; 2024 Jun; 250():118434. PubMed ID: 38346483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of Maternal Serum Perfluoroalkyl Substances Concentrations with Early Adolescent Bone Mineral Content and Density: The Health Outcomes and Measures of the Environment (HOME) Study.
    Buckley JP; Kuiper JR; Lanphear BP; Calafat AM; Cecil KM; Chen A; Xu Y; Yolton K; Kalkwarf HJ; Braun JM
    Environ Health Perspect; 2021 Sep; 129(9):97011. PubMed ID: 34585601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of per- and polyfluoroalkyl substances (PFAS) and their mixture with oxidative stress biomarkers during pregnancy.
    Taibl KR; Schantz S; Aung MT; Padula A; Geiger S; Smith S; Park JS; Milne GL; Robinson JF; Woodruff TJ; Morello-Frosch R; Eick SM
    Environ Int; 2022 Nov; 169():107541. PubMed ID: 36191484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between prenatal exposure to per- and polyfluoroalkyl substances and infant anthropometry: A prospective cohort study.
    Li J; Su X; Zhou Y; Ji H; Xie Z; Sun S; Wang Z; Yuan W; Miao M; Liang H
    Int J Hyg Environ Health; 2024 Apr; 257():114339. PubMed ID: 38401404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma concentrations of per- and polyfluoroalkyl substances are associated with perturbations in lipid and amino acid metabolism.
    Prince N; Begum S; Mínguez-Alarcón L; Génard-Walton M; Huang M; Soeteman DI; Wheelock C; Litonjua AA; Weiss ST; Kelly RS; Lasky-Su J
    Chemosphere; 2023 May; 324():138228. PubMed ID: 36878362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.